HIGH RISK OF ADVERSE EVENTS AFTER AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN LYMPHOMA PATIENTS WITH DNA REPAIR PATHWAY MUTATIONS: A NATION‐WIDE COHORT STUDY. (12th June 2019) - Husby, S.